ghk-cu stability light exposure Frontiers How GHK-Cu Tightens Loose Skin:

Anxiety is a secondary concern

Anyone with active cancer or undergoing cancer treatment p53 and senescence pathways interact with tumor biology in complex ways

Comparing the Two: Which Is More Effective

Data Animal Data In pregnant rats given daily subcutaneous doses of zoledronic acid of 0.1, 0.2, or 0.4 mg/kg during organogenesis, fetal skeletal, visceral, and external malformations, increases in pre-and post-implantation loss, and decreases in viable fetuses and fetal weight were observed at 0.2 and 0.4 mg/kg/day (equivalent to 2 and 4 times the human 5 mg intravenous dose, based on AUC)

doi:10.7759/cureus.29923